Tomohiko Shiina

Mibu, 3210293, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.

A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.

Journal: Neurological research and practice

Published: April 22, 2025

Impact of autonomic symptoms on the clinical course of Parkinson's disease.

Impact of autonomic symptoms on the clinical course of Parkinson's disease.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: December 29, 2023

Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule.

Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule.

Journal: Journal of the neurological sciences

Published: October 03, 2023

Impact of diabetes and glycated hemoglobin level on the clinical manifestations of Parkinson's disease.

Impact of diabetes and glycated hemoglobin level on the clinical manifestations of Parkinson's disease.

Journal: Journal of the neurological sciences

Published: August 03, 2023

Real-world effectiveness of erenumab in Japanese patients with migraine.

Real-world effectiveness of erenumab in Japanese patients with migraine.

Journal: Heliyon

Published: June 29, 2023

Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan.

Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan.

Journal: Cephalalgia : an international journal of headache

Published: May 26, 2023

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan.

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan.

Journal: Frontiers in neurology

Published: May 10, 2023

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study.

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study.

Journal: Journal of neurology

Published: April 25, 2023

Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease.

Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease.

Journal: Frontiers in neurology

Published: November 13, 2022

Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?

Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?

Journal: Journal of the neurological sciences

Published: August 16, 2022

Central Sensitization in Migraine: A Narrative Review.

Central Sensitization in Migraine: A Narrative Review.

Journal: Journal of pain research

Published: May 27, 2022

Sleep and Autonomic Manifestations in Parkinson's Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder.

Sleep and Autonomic Manifestations in Parkinson's Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder.

Journal: Frontiers in neuroscience

Published: February 12, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026